Brain-derived gangliosides induce cell cycle arrest in a murine T cell line

Journal of Neuroimmunology

Volumn 87, Issue 1-2, 1998, Pages 11-16

  Irani, David N ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Gangliosides; Immune regulation; Retinoblastoma protein; T lymphocytes

Indexed keywords

GANGLIOSIDE;

ANIMAL CELL; ARTICLE; CELL CYCLE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

3T3 CELLS; ANIMALS; BRAIN; CELL CYCLE; CELL DIVISION; CELL LINE; GANGLIOSIDES; INTRACELLULAR MEMBRANES; MICE; PHOSPHORIC MONOESTER HYDROLASES; PHOSPHORYLATION; RETINOBLASTOMA PROTEIN; T-LYMPHOCYTES;

EID: 0032126952     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(98)00038-1     Document Type: Article

References (31)

1. Buchkovich, K., Duffy, L.A., Harlow, E., 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105.
2. Cavaillon, J.-M., Fitting, C., 1986. Inhibition of lipopolysaccharide-induced monocyte interleukin-1 secretion by gangliosides. Eur. J. Immunol. 16, 1009-1012.
3. Chao, R., Khan, W., Hannun, Y.A., 1992. Retinoblastoma protein dephosphorylation induced by D-erythro-sphingosine. J. Biol. Chem. 267, 23459-23462.
4. Cheresh, D.A., Pierschbacher, M.D., Herzig, M.A., Mujoo, K., 1986. Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102, 683-689.
5. Chu, J.W.K., Sharom, F.J., 1993. Gangliosides inhibit T-lymphocyte proliferation by preventing the interaction of interleukin-2 with its cell surface receptor. Immunology 79, 10-17.
6. Dbaibo, G.S., Pushkareva, M.Y., Jayadev, S., Schwarz, J.K., Horowitz, J.M., Obeid, L.M., Hannun, Y.A., 1995. Retinoblastoma gene product as a downstream target for a ceramide-dependent pathway of growth arrest. Proc. Natl. Acad. Sci. USA 92, 1347-1351.
7. Dobrowsky, R.T., Hannun, Y.A., 1992. Ceramide stimulates a cytosolic protein phosphatase. J. Biol. Chem. 267, 5048-5051.
8. Farrar, J.J., Fuller-Farrar, J., Simon, P.L., Hilfiker, M.L., Stadler, B.M., Farrar, W.L., 1980. Thymoma production of T cell growth factor (interleukin 2). J. Immunol. 125, 2555-2558.
9. Gorer, P.A., 1950. Studies in antibody response of mice to tumour inoculation. Br. J. Cancer 4, 372-379.
10. Hannun, Y.A., Obeid, L.M., 1995. Ceramide: an intracellular signal for apoptosis. Trends Biochem. Sci. 20, 73-77.
11. Irani, D.N., Lin, K.-I., Griffin, D.E., 1996. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol. 157, 4333-4340.
12. Irani, D.N., Lin, K.-I., Griffin, D.E., 1997. Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. 158, 2318-2326.
13. Jacks, T., Fazeli, A., Schmitt, E.M., Bronson, R.T., Goodell, M.A., Weinberg, R.A., 1992. Effects of an Rb mutation in the mouse. Nature 359, 295-300.
14. Ledeen, R.W., Yu, R.K., 1982. Gangliosides: structure, isolation, and analysis. Methods Enzymol. 83, 139-191.
15. Lowenthal, J.W., Cerottini, J.C., MacDonald, H.R., 1986. Interleukin 1-dependent induction of both interleukin 2 secretion and interleukin 2 receptor expression by thymoma cells. J. Immunol. 137, 1226-1231.
16. Mamoi, T., 1986. Activation of protein kinase C by ganglioside GM3 in the presence of calcium and 12-O-tetradecanoylphorbol-13-acetate. Biochem. Biophys. Res. Commun. 138, 865-873.
17. Massa, P.T., 1993. Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides. J. Exp. Med. 178, 1357-1363.
18. Mathias, S., Younes, A., Kan, C.-C., Orlow, I., Joseph, C., Kolesnick, R.N., 1993. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1β. Science 259, 519-522.
19. Mercep, M., Bluestone, J.A., Noguchi, P.D., Ashwell, J.D., 1987. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules. J. Immunol. 140, 324-335.
20. Nelson, D.A., Krucher, N.A., Ludlow, J.W., 1997. High molecular weight protein phosphatase type 1 dephosphorylates the retinoblastoma protein. J. Biol. Chem. 272, 4528-4535.
21. Offner, H., Thieme, T., Vandenbark, A.A., 1987. Gangliosides induce selective modulation of CD4 from helper T lymphocytes. J. Immunol. 139, 3295-3305.
22. Robb, R.J., 1986. The suppressive effect of gangliosides upon IL 2-dependent proliferation as a function of inhibition of IL 2-receptor association. J. Immunol. 136, 971-976.
23. Skaper, S.D., Leon, A., Toffano, G., 1989. Ganglioside function in the development and repair of the nervous system. Mol. Neurobiol. 3, 173-199.
24. Spagnoli, G.C., Ausiello, C.M., Sconocchia, G., Adorno, D., Casciani, C.U., 1991. Gangliosides potentiate cyclosporin A-induced suppression of allospecific immune responses. Transplant. Proc. 23, 342-345.
25. Stults, C.L.M., Sweeley, C.C., Macher, B.A., 1989. Glycosphingolipids: structure, biological source, and properties. Methods Enzymol. 179, 167-214.
26. Tan, X., Martin, S.J., Green, D.R., Wang, J.Y.J., 1997. Degradation of the retinoblastoma protein in tumor necrosis factor- and CD95-induced cell death. J. Biol. Chem. 272, 9613-9616.
27. Weinberg, R.A., 1995. The retinoblastoma protein and cell cycle control. Cell 81, 323-330.
28. Whisler, R.L., Yates, A.J., 1980. Regulation of lymphocyte responses by human gangliosides: I. Characteristics of inhibitory effects and the induction of impaired activation. J. Immunol. 125, 2106-2111.
29. Wiegandt, H., 1971. Glycosphingolipids. Adv. Lipid Res. 9, 249-289.
30. Yang, L.J.-S., Zelled, C.B., Shaper, N.L., Kiso, M., Hasegawa, A., Shapiro, R.E., Schnaar, R.L., 1996. Gangliosides are neuronal ligands for myelin-associated glycoprotein. Proc. Natl. Acad. Sci. USA 93, 814-818.
31. Ziegler-Heitbrock, H.W.L., Kafferlein, E., Haas, J.G., Meyer, N., Strobel, M., Weber, C., Flieger, D., 1992. Gangliosides suppress tumor necrosis factor production in human monocytes. J. Immunol. 148, 1753-1758.